Exco InTouch, the leading provider of patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, today announced that it has now formally received U.S.- EU Safe Harbor Framework and U.S.- Swiss Safe Harbor Framework Self Certification status by the U.S. Department of Commerce’s International Trade Administration (ITA). The designation certifies that Exco InTouch’s practices meet or exceed the data privacy and security standards outlined by The European Commission’s Directive on data protection.
The U.S. Department of Commerce, in consultation with the European Commission, developed the Safe Harbor framework in order to bridge the gap between EU/Switzerland and U.S. approaches to privacy protection and provide a streamlined means for U.S. organisations to comply with the Commission’s Directive. In order to be recognised for the certification, Exco InTouch has demonstrated that its customer privacy procedures comply with the seven ‘Safe Harbor Privacy Principles’ which cover notice, choice, transfers to third parties, access, security, data integrity and enforcement. As a result, Exco InTouch’s customers, for whom the company provides mobile and digital patient engagement solutions, can be reassured that their programs comply with these stringent privacy and security safeguards.
“Protecting the privacy and confidentiality of personal information has always been, and will remain, the highest priority for Exco InTouch,” says Mike Hansen, COO and Co-Founder of Exco InTouch. “The U.S. – EU and US – Swiss Safe Harbor Certification will not only help to streamline our data transfer processes between the EU/Switzerland and U.S, but will also provide our customers with further reassurance that we are fully compliant with the highest standards of data protection.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.